Novarapid Penfil 100 mg Injection is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above two years of age) and adults. The active ingredient in Novarapid Penfil 100 mg Injection is insulin aspart. Diabetes is a medical condition where your body does not produce enough insulin to control your blood sugar level. Treatment with Novarapid Penfil 100 mg Injection helps to prevent complications from your diabetes.

Novarapid Penfil 100 mg Injection contains Insulin Aspart, it is extremely fast-acting and works rapidly to normalise blood sugar levels. It typically begins working after 10-20 minutes and lasts between 3 and 5 hours. Due to this short action, Novarapid Penfil 100 mg Injection should usually be taken with intermediate-acting or long-acting insulin preparations. Novarapid Penfil 100 mg Injection works by ensuring rapid and consistent sugar control. Novarapid Penfil 100 mg Injection is a fast-acting form of insulin that helps lower blood sugar levels after food intake. It prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver.

Your doctor will advise you on how to use Novarapid Penfil 100 mg Injection. It should be administered at least 5-10 minutes before the meal or within 20 minutes after you start having a meal. The common side effects of Novarapid Penfil 100 mg Injection are hypokalaemia (low potassium), hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin), which may occur at the injection site. Most of these side effects of Novarapid Penfil 100 mg Injection do not require medical attention and gradually resolve over time. However, if the side effects persist, contact your doctor.

Try not to stop taking Novarapid Penfil 100 mg Injection of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Do not take Novarapid Penfil 100 mg Injection if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs. Along with Novarapid Penfil 100 mg Injection, you should take a healthy diet, exercise regularly, and maintain weight as your doctor advises. Novarapid Penfil 100 mg Injection is a cold chain medicine, so it must be stored in the refrigerator between 2-8 degrees Celsius; otherwise, its efficiency might get lost. Do not store it in the fridge freezer.

Novarapid Penfil 100 mg Injection is administered 5-10 minutes before taking meal subcutaneously (SC) in the abdomen or thigh region. It can also be given intravenously (IV) with 0.9% sodium chloride infusion. However, subcutaneous injection of Novarapid Penfil 100 mg Injection in the abdomen region ensures faster absorption than other injection sites. Novarapid Penfil 100 mg Injection is usually given once or twice daily when both rapid and prolonged insulin effects are desired. In the initial requirement, the dose requirement is generally between 0.3 and 1.0 IU/kg per day. An injection of Novarapid Penfil 100 mg Injection should be followed within 30 minutes by a meal or snack containing sugar/glucose (carbohydrates). If you are not well trained to self-administer Novarapid Penfil 100 mg Injection, ask a healthcare professional to administer it.

Procedure for self-injecting insulin:

• You should wash your hands first before injecting insulin.

• Then roll the insulin bottle and wipe the bottle top.

• Now pull the plunger of the syringe down to an appropriate number of units your doctor has prescribed.

• Push the needle into the bottle and push the syringe plunger down.

• Now, once again, pull the plunger down to an appropriate number of units as the doctor prescribes.

• Pick the injection site and wipe it with an alcohol swab. Now, pinch up the skin, push the needle into the skin and then push the plunger in.

• The needle should be kept under the skin for at least 6 seconds to make sure the entire dose is injected.

• After injecting the insulin, pull out the needle and dispose of the syringe safely. And then you can have a meal or snack.

Novarapid Penfil 100 mg Injection works by ensuring rapid and consistent sugar control. Novarapid Penfil 100 mg Injection is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. It prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver. Novarapid Penfil 100 mg Injection helps in improving the glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage to the retina (retinopathy), damage to the kidney (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others. Besides this, Novarapid Penfil 100 mg Injection can be safely prescribed to the diabetic mother during pregnancy and lactation.

Novarapid Penfil 100 mg Injection is for subcutaneous (under the skin) use only and should never be administered intravenously (IV) or in the veins. If you are changing the brand of insulin or if you need to inject your insulin by another method, it should be done under strict medical supervision. Cases of heart failure were reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Novarapid Penfil 100 mg Injection may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take Novarapid Penfil 100 mg Injection if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs.